{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:38Z","timestamp":1774485518386,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Swine are an important host of Japanese encephalitis virus (JEV). The two membrane glycoproteins of JEV, prM and E, each contain a potential N-linked glycosylation site, at positions N15 and N154, respectively. We constructed plasmids that contain the genes encoding wild-type prME (contain the signal of the prM, the prM, and the E coding regions) and three mutant prME proteins, in which the putative N-linked glycosylation sites are mutated individually or in combination, by site-directed mutagenesis. The recombinant plasmids were used as DNA vaccines in mice. Our results indicate that immunizing mice with DNA vaccines that contain the N154A mutation results in elevated levels of interleukin-4 secretion, induces the IgG1 antibody isotype, generates greater titers of anti-JEV antibodies, and shows complete protection against JEV challenge. We conclude that mutation of the putative N-glycosylation site N154 in the E protein of JEV significantly enhances the induced humoral immune response and suggest that this mutant should be further investigated as a potential DNA vaccine against JEV.<\/jats:p>","DOI":"10.1186\/1743-422x-8-138","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T18:19:32Z","timestamp":1301681972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mutation of putative N-Linked Glycosylation Sites in Japanese encephalitis Virus Premembrane and Envelope proteins enhances humoral immunity in BALB\/C mice after DNA vaccination"],"prefix":"10.1186","volume":"8","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruibing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,25]]},"reference":[{"key":"1273_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-625380-1.50008-4","volume-title":"The togaviruses","author":"RE Shope","year":"1980","unstructured":"Shope RE: Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. The togaviruses. Edited by: Schlesinger RW. 1980, New York: Academic Press, 47-82."},{"key":"1273_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-4757-0785-4_12","volume-title":"The Togaviridae and Flaviviridae","author":"TP Monath","year":"1986","unstructured":"Monath TP: Pathobiology of the flaviviruses. The Togaviridae and Flaviviridae. Edited by: Schlesinger S, Schlesinger MJ. 1986, New York: Plenum Press, 375-440."},{"key":"1273_CR3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4269\/ajtmh.1959.8.698","volume":"8","author":"WF Scherer","year":"1959","unstructured":"Scherer WF, Moyer J, Izumi T, Gresser I, McCown J: Ecologic studies of Japanese encephalitis virus in Japan: VI, Swine infection. Am J Trop Med Hyg. 1959, 8: 698-706.","journal-title":"Am J Trop Med Hyg"},{"key":"1273_CR4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.1999.61.677","volume":"61","author":"S Vrati","year":"1999","unstructured":"Vrati S, Giri RK, Razdan A, Malik P: Complete nucleotide sequence of and Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis. Am J Trop Med Hyg. 1999, 61: 677-680.","journal-title":"Am J Trop Med Hyg"},{"key":"1273_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome organization, expression and replication. Annu Rev Microbiol. 1990, 44: 649-10.1146\/annurev.mi.44.100190.003245.","journal-title":"Annu Rev Microbiol"},{"key":"1273_CR6","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1128\/jvi.70.12.8765-8772.1996","volume":"70","author":"Y Chen","year":"1996","unstructured":"Chen Y, Maguire T, Marks RM: Demonstration of Binding of Dengue Virus Envelope protein to Target Cells. J. Virol. 1996, 70: 8765-8772.","journal-title":"J. Virol"},{"key":"1273_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","volume":"78","author":"JJ Hung","year":"2004","unstructured":"Hung JJ, Hsieng MT, Young MJ, Kao CL, King CC, Chang W: An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells. J Virol. 2004, 78: 378-388. 10.1128\/JVI.78.1.378-388.2004.","journal-title":"J Virol"},{"key":"1273_CR8","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/jvi.67.3.1672-1675.1993","volume":"67","author":"E Konishi","year":"1993","unstructured":"Konishi E, Mason PW: Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 1993, 67: 1672-16755.","journal-title":"J. Virol"},{"key":"1273_CR9","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","volume":"69","author":"SL Allison","year":"1995","unstructured":"Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX: Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 1995, 69: 5816-5820.","journal-title":"J. Virol"},{"key":"1273_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","volume":"74","author":"MP Courageot","year":"2000","unstructured":"Courageot MP, Frenkiel MP, Dos Santos CD, Deubel V, Despres P: \u03b1-Glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J. Virol. 2000, 74: 564-572. 10.1128\/JVI.74.1.564-572.2000.","journal-title":"J. Virol"},{"key":"1273_CR11","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","volume":"72","author":"E Konishi","year":"1998","unstructured":"Konishi E, Yamaoka M, Win KS, Kurane I, Mason PW: Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol. 1998, 72: 4925-4930.","journal-title":"J Virol"},{"key":"1273_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/glycob\/cwh106","volume":"14","author":"Zhang Ming","year":"2004","unstructured":"Ming Zhang, Brian Gaschen, Wendy Blay, Brian Foley, Nancy Haigwood: Tracking global patterns of N-linked glycosylation site variation highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology. 2004, 14: 1229-1246. 10.1093\/glycob\/cwh106.","journal-title":"Glycobiology"},{"key":"1273_CR13","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","volume":"79","author":"A Goffard","year":"2005","unstructured":"Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C: Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol. 2005, 79: 8400-8409. 10.1128\/JVI.79.13.8400-8409.2005.","journal-title":"J Virol"},{"key":"1273_CR14","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.vaccine.2004.11.068","volume":"23","author":"A Goto","year":"2005","unstructured":"Goto A, Yoshii K, Obara M, Ueki T, Mizutani T, Kariwa H, Takashima I: Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine. 2005, 23: 3043-3052. 10.1016\/j.vaccine.2004.11.068.","journal-title":"Vaccine"},{"key":"1273_CR15","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1099\/vir.0.19308-0","volume":"84","author":"HY Wei","year":"2003","unstructured":"Wei HY, Jiang LF, Fang DY, Guo HY: Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides. J Gen Virol. 2003, 84: 3095-3098. 10.1099\/vir.0.19308-0.","journal-title":"J Gen Virol"},{"key":"1273_CR16","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1128\/JVI.00789-08","volume":"82","author":"MK Jeong","year":"2008","unstructured":"Jeong MK, Sang IY, Byung HS, Youn SH, Chan HL, Hyun WO, Young ML: A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice. J Virol. 2008, 82: 7846-7862. 10.1128\/JVI.00789-08.","journal-title":"J Virol"},{"issue":"25-26","key":"1273_CR17","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","volume":"21","author":"E Konishi","year":"2003","unstructured":"Konishi E, Ajiro N, Nukuzuma C: Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine. 2003, 21 (25-26): 3675-3683. 10.1016\/S0264-410X(03)00382-7.","journal-title":"Vaccine"},{"key":"1273_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/338015","volume":"185","author":"R Kaur","year":"2002","unstructured":"Kaur R, Sachdeva G, Vrati S: Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis. 2002, 185: 1-12. 10.1086\/338015.","journal-title":"J Infect Dis"},{"key":"1273_CR19","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","volume":"21","author":"SC Wu","year":"2003","unstructured":"Wu SC, Yu CH, Lin CW, Chu IM: The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity. Vaccine. 2003, 21: 2516-22. 10.1016\/S0264-410X(03)00042-2.","journal-title":"Vaccine"},{"key":"1273_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome organization, expression, and replication. Annual Review of Microbiology. 1990, 44: 649-688. 10.1146\/annurev.mi.44.100190.003245.","journal-title":"Annual Review of Microbiology"},{"key":"1273_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","volume":"96","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Nisalak A, Endy TP, Suntayakorn S, Vaughn DW, Innis BL: Clinical and immunological risk factors for severe disease in Japanese encephalitis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002, 96: 173-178. 10.1016\/S0035-9203(02)90294-4.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"1273_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/viro.1999.0142","volume":"268","author":"E Konishi","year":"2000","unstructured":"Konishi E, Yamaoka M, Kurane I, Mason PW: Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology. 2000, 268: 49-55. 10.1006\/viro.1999.0142.","journal-title":"Virology"},{"key":"1273_CR23","first-page":"309","volume-title":"Control of Virus Diseases","author":"A Igarashi","year":"1992","unstructured":"Igarashi A: Japanese encephalitis: virus, infection, and control. Control of Virus Diseases. Edited by: Kurstak E. 1992, Marcel Dekker, New York, USA, 309-342. second","edition":"second"},{"key":"1273_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(99)00104-0","volume":"229","author":"UA Hasan","year":"1999","unstructured":"Hasan UA, Abai AM, Harper DR, Wren BW, Morrow WJW: Nucleic acid immunisation: concepts and techniques associated with third generation vaccines. J Immunol Methods. 1999, 229: 1-22. 10.1016\/S0022-1759(99)00104-0.","journal-title":"J Immunol Methods"},{"key":"1273_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/13550280390218454","volume":"9","author":"R Kaur","year":"2003","unstructured":"Kaur R, Vrati S: Development of a recombinant vaccine against Japanese encephalitis. J Neurovirol. 2003, 9: 421-431.","journal-title":"J Neurovirol"},{"key":"1273_CR26","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.73.3.2094-2098.1999","volume":"73","author":"S Kodihalli","year":"1999","unstructured":"Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, Webster RG: DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol. 1999, 73: 2094-","journal-title":"J Virol"},{"key":"1273_CR27","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/eji.1830241017","volume":"24","author":"B Doe","year":"1994","unstructured":"Doe B, Steimer KS, Walker CM: Induction of HIV-1 envelope (gp120)- specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur J Immunol. 1994, 24: 2369-10.1002\/eji.1830241017.","journal-title":"Eur J Immunol"},{"key":"1273_CR28","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1016\/j.vaccine.2007.07.003","volume":"25","author":"Liu Min","year":"2007","unstructured":"Min Liu, Zhang Xiao-Lian: Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses. Vaccine. 2007, 25: 6572-6580. 10.1016\/j.vaccine.2007.07.003.","journal-title":"Vaccine"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:21:24Z","timestamp":1630502484000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-138","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,25]]},"assertion":[{"value":"4 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"138"}}